Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ledipasvir/Sofosbuvir for Acute HCV/HIV Co-infection
NCT02457611Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ledipasvir, sofosbuvir in hepatitis C virus infection, sponsored by Gilead Sciences. Started Jun 2015; status: completed.
02
Drugs
ledipasvirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02457611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457611.